Colchicine, COVID-19 and hematological parameters: A meta-analysis

Musharraf Sarwar1, Zahid Ali2, Mahnoor Fatima1

  • 1University College of Medicine and Dentistry, Lahore, Pakistan.

Summary

Colchicine effectively reduces inflammatory biomarkers like C-reactive protein, lactate dehydrogenase, and D-dimer in COVID-19 patients. This anti-inflammatory drug shows promise as an adjunct therapy for moderate-to-severe cases.